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Background：Diagnosing cardioembolic stroke due to paroxysmal atrial fibrillation（PAF）is difficult, 
mainly due to low detection rate. We evaluated whether left atrial volume, which can be simply measured 
using non-contrast chest computed tomography（CT-LAV）, can contribute to the diagnosis of cardioem-
bolic stroke due to PAF（PAF-CE）.
Methods：Fifty-one consecutive patients with acute ischemic stroke within 24 h of onset were included 
in this study. Upon admission, we measured the left atrial diameter using transthoracic echocardiography
（TTE-LAD）and CT-LAV. Patient background factors such as sex, age, and stroke risk factors were 
noted as well as brain natriuretic peptide（BNP）value and QTc interval were evaluated on admission. Util-
ities of BNP value, CT-ALV, and TTE-LAD in PAF-CE diagnosis were compared.
Results：Patients were classified into three groups：cerebral thrombosis（CTB）group including large-
artery atherosclerosis and small-vessel occlusion（n＝16）, cardioembolic stroke due to non-valvular atrial 
fibrillation（AF-CE）group（n＝20）, and cardioembolic stroke due to paroxysmal atrial fibrillation（PAF-
CE）group（n＝15）. BNP value was highest in the AF-CE group（240.5 pg/mL）, followed by the PAF-CE
（187.9 pg/mL）and CTB groups（35.0 pg/mL）（p＜0.001）. There was a significant difference in TTE-LAD 
among the groups（AF-CE group, 43.8 mm；PAF-CE group, 38.3 mm；CTB group, 34.1 mm）（p＜0.001）. 
CT-LAV was higher in the AF-CE group（142 mm3）than in the PAF-CE（95.8 mm3）and CTB groups
（95.8 mm3）（p＜0.001）. In differentiating PAF-CE, the area under the receiver operating characteristic 
curve was 0.867, 0.742, and 0.845 for BNP value, TTE-LAD, and CT-LAV, respectively. A cut-off CT-
LAV value of ≥  69.6 mm3 had a high diagnostic rate（＞80％ of sensitivity, specificity, positive predictive 
value, negative predictive value, and accuracy）.
Conclusion：CT-LAV can be useful in diagnosing PAF-CE. Further studies with larger sample size are 
required to confirm our findings and determine better cut-off value for CT-LAV.
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INTRODUCTION
Cardioembolic stroke resulting from non-valvular 
atrial fibrillation（NVAF）（AF-CE）is known to result 
in poor outcomes, with many cases leading to in-hos-
pital death 1）. There are also some cases of cerebral 
embolism in which the embolic source cannot be 
detected. These cases are described as embolic 
strokes of undetermined source（ESUS）2）. When treat-
ing ESUS, the efficacy of antithrombotic agents for 
secondary prevention is unclear, and aspirin is cur-
rently recommended as the better choice 3）. However, 
in terms of causes of cardioembolic stroke, paroxysmal 
atrial fibrillation（PAF）is also known to be associated 
with a high primary risk for ischemic stroke 4）. 
Approximately 30％ of cases of ESUS are thought to 
be caused by PAF5）, and some patients require treat-
ment with an anticoagulant agent as secondary pre-
vention.
Patients who do not exhibit NVAF at the time of 
ischemic stroke onset require long-term electrocardi-
ography（ECG）monitoring. As the PAF detection rate 
for 24-h observation is only 2.9％ , ECG monitoring 
must be performed for at least 72 h 1）. Therefore, vari-
ous tests are performed to differentiate cardioembolic 
stroke due to PAF6,7）. Transthoracic echocardiogra-
phy（TTE）can be used simply and noninvasively to 
measure left atrial diameter（LAD）. TTE-LAD dilata-
tion is a finding that is suggestive of the presence of 
PAF8〜10）. However, there is a risk of measurement 
error resulting from difference in body position during 
testing or technical skill of the tester.
As aortic arch calcification detected via chest com-
puted tomography（CT）is also known to be a risk 
factor for ischemic stroke 11）, many patients are 
assessed for ischemic stroke upon admission.
Therefore, we measured simple left atrial volume
（CT-LAV）with non-contrast chest CT in patients 
with acute ischemic stroke and investigated whether 
these values were useful in diagnosing cardioembolic 
stroke due to PAF（PAF-CE）.
MATERIALS AND METHODS
We retrospectively observed a total of 238 patients, 
including 158 with large-artery atherosclerosis and 
small-vessel occlusion and 80 with cardioembolic 
stroke due to NVAF or PAF who were hospitalized 
between April 2014 and March 2018 at the Depart-
ment of Neurology, Dokkyo Medical University Hospi-
tal, and whose condition developed within 24 h after 
admission. Ischemic stroke was classified using the 
Stop Stroke Study TOAST（SSS-TOAST）by Ay et 
al 4）. Definitive diagnosis of PAF-CE was defined as 
meeting the ESUS diagnostic criteria 2）upon admission 
and NVAF being noted during hospitalization.
Brain natriuretic peptide（BNP）levels were 
observed with blood testing during admission as well 
as QTc interval on ECG testing. Smoking, daily alco-
hol consumption, hypertension, dyslipidemia, and dia-
betes mellitus were evaluated as risk factors for cere-
brovascular disease. We also investigated the duration 
of hospitalization.
We excluded patients who did not undergo BNP or 
QTc interval evaluation while being hospitalized and 
patients who did not undergo non-contrast chest CT 
or TTE within 24 h after hospitalization as well as 
those with cryptogenic stroke and stroke of other 
determined etiologies including ESUS.
Evaluation of TTE-LAD and CT-LAV
TTE was performed using Vivid7（GE Healthcare 
Japan）, Vivid E9（GE Healthcare Japan）, Sonos-7500
（Philips, Japan）, and iE33（Philips, Japan）. We used a 
sector-array probe in the parasternal long-axis view 
to measure TTE-LAD.
In non-contrast chest CT, we used Aquilion CXL
（Canon Medical Systems, Japan）, Aquilion One Vision 
edition（Canon Medical Systems, Japan）, Sensation 40
（Siemens Healthineers, Japan）, and Sensation 64（Sie-
mens Healthineers, Japan）with the horizontal section-
al view. Imaging conditions were mediastinal window
（window level 50, window width 400）with slice thick-
ness of 0.5 mm or 0.8 mm. CT-LAV was calculated 
with the following formula.
CT-LAV（mm3）＝longitudinal diameter（mm）×lateral 
diameter（mm）×number of slice×slice width（5 or 8）
/2
Statistical analysis
Subjects were divided into a cerebral thrombosis
（CTB）group（large-artery atherosclerosis and small-
vessel occlusion）, AF-CE group, and PAF-CE group. 
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We analyzed sex, risk factors, duration of hospitaliza-
tion, QTc interval, BNP level, TTE-LAD, and CT-
LAV differences in each group. The statistical soft-
ware used was SPSS Statistics version 25（IBM）. We 
used Pearson’s chi-square test to analyze categorical 
variables. When analyzing continuous variables, we 
used the Mann-Whitney U test for comparisons 
between two groups and the Kruskal-Wallis test for 
comparisons between three groups. A P-value ＜0.05 
indicated a statistically significant difference.
We used the receiver operating characteristic
（ROC）curve to investigate PAF-CE diagnosis sensi-
tivity and specificity, positive predictive value（PPV）, 
negative predictive value（NPV）, and accuracy. In 
addition, we used univariate logistic regression to cal-
culate odds ratios.
Ethical standard
All procedures followed were in accordance with 
the ethical standards of the responsible committee on 
human experimentation（institutional and national）
and the 1975 Declaration of Helsinki, as revised in 
2008. The institutional review board of Dokkyo Medi-
cal University Hospital approved the study（IRB 
approved number, R-8-8）. All patients provided writ-
ten informed consent to participate.
RESULTS
Investigation of three groups
Of the total 238 patients, 16 were classified in the 
CTB group, 20 in the AF-CE group, and 15 in the 
PAF-CE group, and 187 patients were excluded. Male 
patients accounted for 68.8％ of the CTB group, 40.0
％ of the AF-CE group, and 80.0％ of the PAC-CE 
group, indicating that there were fewer men in the 
AF-CE group（p＜0.05）. However, there were no dif-
ferences noted for age, smoking, daily alcohol con-
sumption, and duration of hospitalization, and no sig-
nificant differences were observed for the prevalence 
of hypertension, dyslipidemia, or diabetes mellitus
（Table 1）.
The QTc interval was 0.434 s（median）in the CTB 
group, 0.446 s in the AF-CE group, and 0.451 s in the 
PAF-CE group, indicating no significant differences（p
＝0.109）. The BNP level was highest in the AF-CE 
group, at 240.5 pg/mL（median）. It was elevated in 
the PAF-CE group, at 187.9 pg/mL, but within the 
normal range in the CTB group, at 35.0 pg/mL（p＜
0.001）. TTE-LAD was 43.8 mm in the AF-CE group, 
38.3 mm in the PAF-CE group, and 34.1 mm in the 
CTB group, indicating an intergroup difference（p＜
0.001）. CT-LAV was highest in the AF-CE group, at 
142 mm3. It was 95.8 mm3 in the PAF-CE group and 
53.7 mm3 in the CTB group（p＜0.001）（Table 2）.
Post hoc analysis
No significant differences were noted between the 
CTB group and the AF-CE group（p＝0.474）and 
PAF-CE group（p＝0.0860）in terms of sex（Pearson’s 
chi-square test）. However, a difference was noted 
Table 1　Clinical background factors among CTB, AF-CE and PAF-CE groups
Groups
p valueCTB
（n＝16）
AF-CE
（n＝20）
PAF-CE
（n＝15）
Male（n, ％） 11（68.8） 8（40.0） 12（80.0） 0.0413＊
Age（years, median；range） 74（43-89） 74.5（66-92） 83（64-93） 0.224　
Smoking（n, ％）  2（12.5） 3（15.0）  1（6.67） 0.746＊
Daily alcohol consumption（n, ％）  2（12.5） 4（20.0）  3（20.0） 0.809＊
Hypertension（n, ％） 13（81.3） 14（70.0） 13（86.7） 0.468＊
Dyslipidemia（n, ％）  8（50.0） 7（35.0）  4（26.7） 0.392＊
Diabetes mellitus（n, ％）  3（18.8） 5（25.0）  3（20.0） 0.889＊
Days of hospitalization（median；range） 15（7-45） 19.5（2-50） 16（10-39） 0.231　
Kruskal-Wallis Test, ＊Pearson’s chi-square test
CTB, cerebral thrombosis；AF, non-valvular atrial fibrillation；PAF, paroxysmal atrial fibrillation；
CE, cardioembolic stroke
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between the AF-CE and PAF-CE groups（p＝0.0180）.
Significant differences were noted in the BNP levels 
between the CTB group with the AF-CE group and 
PAF-CE group. However, no difference was noted 
between the AF-CE and PAF-CE groups（p＝0.298, 
Mann-Whitney U test）. Meanwhile, significant differ-
ences were noted between all groups for TTE-LAD 
and CT-LAV（Mann-Whitney U test）（Fig. 1 A, B, C）.
Comparison of CTB group and PAF-CE group
When diagnosing PAF-CE, ROC area under the 
curve was 0.867 for BNP level, 0.742 for TTE-LAD, 
and 0.845 for CT-LAV, indicating that BNP level and 
CT-LAV were particularly useful（Fig. 2）.
When the BNP cutoff value was set at 79.5 pg/mL 
or above, PAF-CE diagnosis could be made with a 
sensitivity of 86.7％ , specificity of 81.3％ , and accura-
cy of 80.7％ . Investigation of the diagnostic rate when 
Table 2　Comparison of four diagnostic markers among CTB, AF-CE and PAF-CE groups
Group
p value
CTB（n＝16） AF-CE（n＝20） PAF-CE（n＝15）
QTc interval
（sec, median；range）
0.434
（0.400-0.479）
0.446
（0.384-0.556）
0.451
（0.374-0.505）
0.109
BNP
（pg/ml, median；range）
35.0
（6.6-406.2）
240.5
（84.1-609.3）
187.9
（41.7-687.8）
＜0.001
TTE-LAD
（mm, median；range）
34.1
（28.1-45.1）
43.8
（36.7-64.7）
38.3
（33.9-51.3）
＜0.001
CT-LAV
（mm3, median；range）
53.7
（19.9-106）
142
（90.1-411）
95.8
（35.2-138）
＜0.001
Kruskal-Wallis Test
CTB, cerebral thrombosis；AF, non-valvular atrial fibrillation；PAF, paroxysmal atrial fibrillation；
CE, cardioembolic stroke；
BNP, brain natriuretic peptide；TTE, transthoracic echocardiography；LAD, left atrial diameter；
CT, computed tomography；LAV, left atrial volume
Figure 1　Post hoc analysis of BNP, TTE-LAD and CT-LAV
A：BNP, B：TTE-LAD, C：CT-LAV
BNP value was significantly lower in CTB group, but there was no difference between 
PAF-CE group and AF-CE group（Mann–Whitney U test）. TTE-LAD and CT-LAV values 
were lowest in CTB group and highest in AF-CE group（Mann–Whitney U test）.
＊ p＜0.05　＊＊ p＜0.01　＊＊＊ p＜0.001
CTB, cerebral thrombosis；AF, non-valvular atrial fibrillation；PAF, paroxysmal atrial 
fibrillation；CE, cardioembolic stroke；BNP, brain natriuretic peptide；TTE, transthoracic 
echocardiography；LAD, left atrial diameter
CT, computed tomography；LAV, left atrial volume
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the CT-LAV cutoff value was set at 69 .6 mm3 or 
higher indicated that sensitivity, specificity, PPV, and 
NPV were all 80％ or higher, with a higher level of 
80.6％ also achieved for accuracy. However, accuracy 
was low, at just 61.3％ when the TTE-LAD cutoff 
value was set at 37.2 mm or greater（Table 3）.
The results of univariate logistic regression for each 
of these cutoff values indicated that BNP level（p＝
0.00185, odds ratio 19.5, 95％ confidence interval 3.01-
127）and CT-LAV（p＝0.00171, odds ratio 17.3, 95％ 
confidence interval 2.92-103）were useful in diagnos-
ing PAF-CE. However, TTE-LAD was not found to 
be useful（p＝0.214）.
DISCUSSION
We investigated whether QTc interval, BNP level, 
TTE-LAD, and CT-LAV differed between the CTB, 
AF-CE, and PAF-CE groups and found that, while 
BNP level was low in the CTB group, no differences 
were noted in the AF-CE and PAF-CE groups. We 
were also able to prove that TTE-LAD and CT-LAV 
were highest for the AF-CE group and high in the 
PAF-CE group, with a difference noted with the CTB 
group. BNP level and CT-LAV were found to be use-
ful in the differential diagnosis of CTB and PAF-CE, 
which is important when selecting the method of sec-
ondary prevention 12）.
Table 3　Diagnostic rate of PAF-CE using BNP, TTE-LAD and CT-LAV
Sensitivity Specificity PPV NPV Accuracy
BNP ≥  79.5 pg/ml 86.7％ 81.3％ 76.5％ 85.7％ 80.7％
TTE-LAD ≥  37.2 mm 60.0％ 62.5％ 60.0％ 62.5％ 61.3％
CT-LAV ≥  69.6 mm3 80.0％ 81.3％ 80.0％ 81.3％ 80.6％
AF, non-valvular atrial fibrillation；PAF, paroxysmal atrial fibrillation；CE, cardioembolic stroke；
BNP, brain natriuretic peptide；TTE, transthoracic echocardiography；LAD, left atrial diameter；
CT, computed tomography；LAV, left atrial volume；
PPV, positive predictive value；NPV, negative predictive value
Figure 2　 ROC curve of BNP, TTE-LAD and CT-LAV in diagnosis 
of PAF-CE
Area under the ROC curve was 0.867, 0.742 and 0.845 for BNP, 
TEE-LAD and CT-LAV, respectively.
CTB, cerebral thrombosis；AF, non-valvular atrial fibrillation；
PAF, paroxysmal atrial fibrillation；CE, cardioembolic stroke；BNP, 
brain natriuretic peptide；TTE, transthoracic echocardiography；
LAD, left atrial diameter；CT, computed tomography；LAV, left 
atrial volume；ROC curve, receiver operating characteristic curve.
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Although our investigation did not reveal any differ-
ences in QTc interval. QTc interval prolongation is 
known to be a risk factor for NVAF13〜15）. Hoshino et 
al. 7）measured QTc interval upon hospital admission in 
744 ischemic stroke patients and found that PAF was 
likely to be detected in patients with a prolonged QTc 
interval. The cutoff value for this was reportedly 
0.438 s. While we did not detect any statistically sig-
nificant difference, we measured the QTc interval in 
the CTB group as being 0.434 s（median）, while the 
QTc interval in the PAF-CE group was prolonged, at 
0.451 s. Therefore, if the sample size was increased, it 
might be possible to show that QTc interval is useful 
in diagnosing PAF-CE.
As BNP level reflects remodeling of the left atrium, 
it is known to become elevated prior to AF onset and 
associated with left atrial overload 16）. Furthermore, in 
cases of ischemic stroke in the acute stage, elevated 
BNP level is useful for predicting PAF-CE. Fujii et 
al. 8）consider a BNP level of 144 pg/mL or higher to 
be of critical importance. However, Yoshioka et al. 9）
reported that a level of 90 pg/mL or higher is optimal 
for predicting PAF, and they have constructed PAF 
prediction scores using cutoff values of 50 pg/mL, 90 
pg/mL, and 150 pg/mL or higher. Thus, there is no 
optimal cutoff value for elevated BNP level in cases of 
acute ischemic stroke caused by PAF. A meta-analy-
sis of approximately 2,800 patients indicated that BNP 
levels are more elevated in cases of AF-CE and PAF-
CE than in cases of CTB even 72 h after onset 6）. In 
our study, which targeted cases of ischemic stroke 
within 24 h after onset, BNP measurement was also 
performed within 2 4 h after onset . Therefore, 
although median BNP levels in cases of CTB were 
somewhat elevated, at 35.0 pg/mL, they were marked-
ly elevated in cases of AF-CE（240.5 pg/mL）and 
PAF-CE（187.9 pg/mL）. Moreover, in the differential 
diagnosis of CTB and PAF-CE, we found that PAF-
CE could be diagnosed at a higher rate with a BNP 
level of 79.5 pg/mL or higher. While this BNP cutoff 
value is lower than that reported in previous studies, 
it is similar to the value reported by Yoshioka et al. 9）.
In cases of NVAF, structural remodeling causes left 
atrial enlargement, dilatation, cell death, and fibrosis 
on weekly basis 17）. However, left atrial dilatation 
might not only be the result of atrial remodeling relat-
ed to permanent arrhythmia. In fact, left atrial dilata-
tion can arise as a result of thromboembolic cardiolog-
ic factors of the fibrillation unrelated to permanent or 
paroxysmal arrhythmia 18,19）. In addition, it has been 
reported that TTE-LAD can also become dilatated in 
cases of PAF-CE, and PAF-CE diagnosis scores using 
TTE-LAD have been proposed 8〜10）. Fujii et al. 8）have 
suggested that the cutoff value for TTE-LAD should 
be 38.0 mm while Yoshioka et al. 9）suggested 40.0 mm. 
Suissa et al. 10）proposed that a TTE-LAD value larger 
than the normal range should be considered to be a 
finding suggestive of PAF-CE. The results of our 
investigation indicated that TTE-LAD in the CTB 
group was within the normal range, at 34.1 mm. How-
ever, the result was 43.8 mm for the AF-CE group 
and 38.3 mm for the PAF-CE group. When differenti-
ating CTB and PAF-CE, TTE-LAD of 37.2 mm or 
larger is considered to be a finding suggestive of 
PAF-CE, and it is similar to the figure reported by 
Fujii et al. 8）. However, accuracy was not overly high, 
at just 61.3％ . Some patients with ischemic stroke 
cannot maintain a set position during testing, while 
others cannot follow the directions of the tester. Mea-
surement errors may also arise as a result of the tes-
ter’s level of skill. These factors may have been the 
reason why it was unable to achieve a high TTE-
LAD diagnostic rate.
CT-LAV was 53.7 mm3 in the CTB group, 142 mm3 
in the AF-CE group, and 95.8 mm3 in the PAF-CE 
group. Like TTE-LAD, it was high in patients with 
NVAF and PAF. These results suggest that patients 
in whom it is difficult to measure TTE-LAD, CT-
LAV could be useful in diagnosing PAF-CE. We also 
demonstrated that at 69.3 mm3 or higher, PAF-CE 
could be diagnosed with a high accuracy of 80.6％ , 
which is almost the same diagnostic rate as that for 
BNP. To calculate more accurately CT-LAV with 
chest CT imaging, respiration and heart rate need to 
be synchronized. However, as no reports have 
attempted to perform PAF-CE diagnosis using normal 
chest CT, which is used to diagnose conditions such 
as aortic arch calcification and pneumonia, we believe 
that the fact that we were able to obtain findings sug-
gestive of PAF-CE with CT-LAV could be very use-
ful in clinical settings.
Patients determined to have PAF while hospitalized 
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were diagnosed as PAF-CE in this study. However, 
the possibility that some patients exhibited PAF after 
being discharged cannot be ruled out. Moreover, in 
cases of insular infarctions, imbalance of sympathetic 
and parasympathetic activities can cause NVAF to 
develop 20）. Therefore, limitations of this study include 
the possibility that patients with PAF were included 
in the CTB group, possibility that cases of NVAF due 
to ischemic stroke were included in the AF-CE group 
and PAF-CE group, and small sample size.
CONCLUSIONS
Like BNP level, CT-LAV might be useful in diag-
nosing PAF-CE. Furthermore, appropriate cutoff val-
ues need to be determined based on further investiga-
tion on a larger sample size.
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